Roche brings together 100 pioneers in an exciting new area of research

Roche is bringing together some of the brightest minds in a new and exciting field of scientific research, which it is hoped will lead to important new developments in drug discovery.

Quantitative systems pharmacology uses new techniques to examine exactly how drugs work in the body. This research may have many significant implications, including the identification of new targets for drugs within the body, and new markers which will tell us if a drug is likely to work in each individual patient or not.

The meeting – which has an exclusive invitation list to 100 experts in this field – will take place on November 2-3, 2015 at the Roche Innovation Center in New York.

Unlocking future innovation

“We believe systems pharmacology will play an important role in the future of innovative medicines, and we are proud to host a forum for so many leading minds in this area,” said Richard Peck, Global Head Clinical Pharmacology and Chair of the Scientific Organizing Committee.  “It is important to remember that inside ever pill is years of innovation and invention. Finding innovative solutions for unmet medical needs is at the heart of what we do at Roche, and collaboration plays an enormous role in that,” he said.

pRED pioneering research

The meeting is led by Roche Pharma Research and Early Development (pRED), which is keen to take a leadership role in helping to move research forward in systems pharmacology.  The meeting provides an opportunity for pRED scientists and leading academics to share their research and philosophies in the area.

Look out for a summary of the meeting towards the end of the year. In the meantime you can find out more about pRED here.

6 reasons why quantitative systems pharmacology shows great promise in drug discovery and development

It will help us to…

  1. Identify exactly where in the body drugs should be targeting
  2. Predict the safety and efficacy of a drug
  3. Understand why the effectiveness of drugs varies between different people
  4. Identify appropriate patient populations for a certain drug
  5. Find new biomarkers of response
  6. Boost drug development success rates

Attendance will be limited to 100 experts from key disciplines. If you would like to participate, please register your interest at The scientific organizing committee will review all applications and inform you as soon as possible about your application.

Tags: Science